Macure Pharma Uk Limited

Macure Pharma Uk Limited, based in London, is a small, active company founded four years ago. With three employees and £12,569,140 in assets, it’s a modest operation managed by four directors and two owners. The company has a real registered address and regularly imports optical and medical tools and devices, with the last import activity recorded five months ago.

The company operates in the wholesale of pharmaceutical goods industries. Its website is currently unavailable, so it’s unclear if it engages in direct e-commerce or solely operates as a wholesale distributor.

Financially, Macure Pharma Uk Limited presents a mixed picture. Current assets have increased significantly by 160%, reaching £13 million, while bank borrowings have surged by 390%, reaching £9.4 million. Cash reserves have decreased by 9.5%, settling at £1.5 million. Trade debtors have grown by 300%, reaching £11 million, which could indicate a reliance on customer payments. Creditors have also risen sharply, increasing by 190% to £11 million, suggesting increased short-term liabilities. Equity has increased by 71%, reaching £1.9 million, which is a positive sign. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows for flexibility, but the rise in debt warrants attention. The financial statements are audited by Magma Audit LLP.

The substantial increase in debt, coupled with the rise in trade debtors, suggests the company may be experiencing cash flow challenges or aggressively expanding its operations. It's possible the company is investing heavily in inventory or aggressively pursuing new sales, which could explain the increased debt. The rise in equity, however, indicates a solid underlying business performance.

Registered in England/Wales under the registration number 13237576, with a registered address at EC1N 2SW, England, London, 3 Waterhouse Square, 138 - 142 Holborn.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.